Zymeworks Competitors and Similar CompaniesClear all

Zymeworks's competitors and similar companies include NovoCure.

	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Founding Date	Founding Date 2003	Founding Date 2000
Type	Type Public	Type Public
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations Vancouver, CA HQ Seattle, US	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 45519% increase	Employees 1,488
Valuation ($)	Valuation ($) 973.3 m	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) $106m (FY, 2025)	Revenue (est.) $655.4m (FY, 2025)
Net income	Net income ($81.1m) (FY, 2025)	Net income ($136.2m) (FY, 2025)

For sources of this data, please see the company profile

Saint Helier, JE

Employees

1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

Financial